Bay Street News, February, 2019

NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a Fortress Biotech (NASDAQ: FBIO) company, […]

TYME’s novel metabolic-based investigational cancer therapy, SM-88, demonstrated encouraging results and a well-tolerated safety profile in a preliminary analysis from […]

Company now focused on completing plan to resubmit NDA in first half of 2019 PRINCETON, N.J., Feb. 11, 2019 (GLOBE […]

Results for the Fourth Quarter of 2018 Net income attributable to the company of $53.5 million, or $1.13 per diluted […]

WASHINGTON, Feb. 11, 2019 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Todd Rahn as […]

RICHMOND HILL, Ontario, Feb. 11, 2019 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), […]

MONTREAL, Feb. 11, 2019 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that its European subsidiary, […]

TORONTO, Feb. 11, 2019 (GLOBE NEWSWIRE) — Gran Colombia Gold Corp. (TSX: GCM, OTCQX: TPRFF) announced today that has completed […]

TORONTO, Feb. 11, 2019 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and […]

First filters using XBAR™ resonators fabricated Presenting latest on XBAR this June at the International Microwave Symposium (IMS) in Boston, […]